An easy-to-understand guide to dual-sugar testing, the L:M ratio and what permeability results can—and cannot—tell us

Intestinal permeability is invisible. You cannot judge it from a photograph, a single symptom or the appearance of a stool. To study it in a living person, researchers need a safe way to ask a functional question: how do selected molecules move from the intestine into the body under controlled test conditions?

The lactulose–mannitol test answers that question with two sugar probes of different sizes. A person drinks a measured solution, collects urine for a specified period and the laboratory measures how much of each probe was recovered. The idea is elegant: use the molecules themselves as travellers, then study which ones crossed the intestinal barrier.

 

The Gut Barrier Is Selective, Not Sealed

The intestinal lining is not meant to be an impenetrable wall. It must absorb water, electrolytes and digested nutrients while regulating contact between the intestinal contents and the body’s internal environment. That makes it more like a carefully managed border than a sheet of plastic.

Molecules can move through intestinal cells and through regulated spaces between them. Mucus, epithelial cells, tight-junction proteins, immune activity, blood flow and the microbiome all contribute to barrier function. Intestinal permeability describes one functional property within that much larger system.

For the wider biology, read Leaky Gut, Intestinal Permeability & Gut Barrier Function: The Complete Guide.

How the Lactulose–Mannitol Test Works

 

Two Sugars, Two Different Behaviours

Mannitol is a relatively small sugar alcohol. It is generally recovered in urine at a much higher percentage than lactulose and has traditionally served as the smaller probe. Its recovery is influenced by absorptive surface area as well as transit, distribution, kidney clearance and collection conditions.

Lactulose is a larger disaccharide. Its passage across an intact small-intestinal epithelium is more restricted, so increased lactulose recovery is commonly interpreted as evidence of greater passage by the larger probe under the conditions of the test.

Why Use a Ratio?

Both probes experience some of the same influences after they are swallowed: gastric emptying, intestinal transit, distribution, kidney clearance, hydration and urine collection. Expressing lactulose recovery relative to mannitol was designed to reduce some of that shared variation.

The ratio is commonly calculated as the percentage of the administered lactulose dose recovered in urine divided by the percentage of the administered mannitol dose recovered. A relatively high L:M ratio has often been interpreted as altered small-intestinal permeability, but it is not a diagnosis by itself and cannot be compared casually across laboratories.

 

Why the Individual Probes Matter

This is why careful studies may report lactulose recovery, mannitol recovery and the ratio. The ratio remains useful, but it should not erase the components from which it was calculated.

Protocol Matters More Than It First Appears

The test sounds simple, yet small methodological differences can change results. Researchers have called for greater standardisation because studies and laboratories have used different probe doses, fasting instructions, fluids, collection periods, analytical platforms and reference ranges.

·   Probe dose and concentration can affect intestinal contents and recovery.

·   Food, medicines and recent exercise may need to be controlled according to the protocol.

·   Collection timing influences which part of the gastrointestinal tract is being sampled.

·   Missing urine or collecting outside the specified window can distort recovery.

·   Hydration and urine volume need consistent handling.

·   Laboratory methods and limits of detection influence comparability.

·   Reference ranges should match the validated method and population where possible.

A result is therefore not just a property of the person. It is a result produced by the person, the probes, the collection protocol and the laboratory method together. Repeating a test under a different protocol may not create a fair before-and-after comparison.

What the Test Does Not Tell You

The lactulose–mannitol test is not a universal “leaky gut test” that explains every symptom. It does not identify a food intolerance, sequence the microbiome, diagnose IBS, describe bowel transit, measure inflammation directly or show what a person’s stool looks like. It assesses the urinary recovery of selected probes under defined conditions.

It also does not mean intestinal permeability is automatically harmful. Some permeability is essential for absorption. The question is whether probe movement differs from an appropriate reference under a validated protocol—and what that means alongside symptoms, medical history and other investigations.

The difference between movement and barrier testing becomes clearer in Gut Motility Explained: How Your Digestive System Keeps Food Moving and

The Complete Guide to Healthy Digestion: How Your Body Breaks Down Food, Absorbs Nutrients & Supports Whole-Body Health.

Bristol Stool Form and Permeability Are Different Outcomes

A person can have a Bristol Type 4 stool and still have a permeability result that requires interpretation. Another person can have digestive symptoms while an L:M result is within the laboratory’s reference range. Different tools ask different questions.

For symptom context, read IBS Explained: Why Symptoms Differ and Why Personalised Care Matters and

IBS vs IBD: What’s the Difference? Understanding Two Very Different Digestive Conditions.

What About Zonulin Tests?

Zonulin is discussed because of its relationship with tight-junction regulation. However, a zonulin measurement is a biomarker assay, whereas dual-sugar testing functionally examines the recovery of administered probes. Those are not interchangeable approaches.

Reviews have raised concerns about assay specificity, uncertainty around normal values and inconsistent correlations with direct permeability methods. A single commercial zonulin result should therefore not be treated as a complete measure of intestinal permeability or a stand-alone diagnosis.

The distinction is explored further in Zonulin, Gut Barrier Function & Intestinal Permeability Explained.

Other Ways Scientists Study Intestinal Permeability

There is no single perfect permeability test. The most appropriate method depends on the gut region, research question, burden on participants and analytical resources.

How the Test Was Used in the Broth & Co Study

The Broth & Co digestive-wellbeing study assessed several outcomes rather than relying on one gut measurement. These included gastrointestinal symptoms, stool form, food tolerance, quality of life and urinary lactulose and mannitol testing. That broader design matters because symptoms and physiological markers do not always move together.

Among 24 participants tested at baseline, the report identified elevated lactulose recovery in 18 participants (75%), elevated mannitol recovery in 11 (46%) and an elevated L:M ratio in six (25%), using the study protocol’s reference values.

The ratio result should be described as exploratory. A 38% observed change sounds substantial, but the subgroup contained only six participants and the change was not statistically significant. The study therefore did not establish a reliable improvement in the L:M ratio. The significant changes in elevated individual markers remain separate findings within this study design.

Subgroup analysis can be sensible when a marker is already normal for many participants: there may be little room—or reason—for it to fall. At the same time, smaller subgroups reduce statistical certainty and make replication especially important.

Read the complete consumer study summary in Bone Broth Clinical Study: Digestive Wellbeing & Intestinal Permeability Research | Broth & Co.

Should You Order a Lactulose–Mannitol Test?

The test has an established role in research and selected clinical contexts, but it is not a general screening score everyone needs. Digestive symptoms can have many causes, and testing is most useful when the result will answer a clear question and influence appropriate care.

Before testing, it is reasonable to ask which protocol is being used, whether the laboratory has a validated reference range, how collection errors are detected, whether individual recoveries will be reported and who will interpret the result. Persistent or concerning digestive symptoms deserve assessment by a qualified health professional rather than self-treatment based on one online test.

Frequently Asked Questions

What is the lactulose–mannitol test?

It is a dual-sugar test in which measured lactulose and mannitol are swallowed and their urinary recovery is analysed to assess small-intestinal permeability under a defined protocol.

What does the L:M ratio mean?

It is the percentage recovery of lactulose divided by the percentage recovery of mannitol. A higher result may reflect more larger-probe passage, less smaller-probe recovery or both.

Is it a test for “leaky gut”?

It is a recognised permeability test, but “leaky gut” is used loosely online. The result is not a complete gut-health diagnosis and requires protocol-specific interpretation.

Why is urine collected?

Probes that cross the intestine enter the circulation and are filtered by the kidneys. Measuring their urine recovery provides an indirect in-vivo assessment.

Can I compare results from different laboratories?

Not reliably unless dose, instructions, collection time, analytical method and reference ranges are comparable.

Does a normal ratio mean my gut is healthy?

It answers only one functional question under the test conditions. It does not exclude every digestive disorder or describe the microbiome, motility, inflammation, symptoms or diet.

Is zonulin the same as an L:M test?

No. Zonulin is measured as a biomarker; L:M testing measures the recovery of administered sugar probes.

Why report lactulose and mannitol separately?

Because a ratio can change when either component changes. The individual recoveries show the pattern hidden inside the single ratio.

Did the Broth & Co study prove the L:M ratio improved?

No. The six-person elevated-ratio subgroup showed an observed reduction, but it was not statistically significant. Significant changes were reported separately for elevated lactulose and mannitol subgroups.

Continue Exploring

• Leaky Gut, Intestinal Permeability & Gut Barrier Function: The Complete Guide

• Zonulin, Gut Barrier Function & Intestinal Permeability Explained

• Bone Broth Clinical Study: Digestive Wellbeing & Intestinal Permeability Research | Broth & Co

• The Complete Guide to Healthy Digestion: How Your Body Breaks Down Food, Absorbs Nutrients & Supports Whole-Body Health

• Gut Motility Explained: How Your Digestive System Keeps Food Moving

• IBS Explained: Why Symptoms Differ and Why Personalised Care Matters

• IBS vs IBD: What’s the Difference? Understanding Two Very Different Digestive Conditions

• The Gut–Brain Axis Explained

References and Further Reading

• How to perform and interpret intestinal-permeability testing — review

• Standardising the lactulose–mannitol test to minimise error — research

• Understanding urinary lactulose and mannitol measurements — research

• Intestinal permeability and current evaluation methods — review

• Non-invasive biomarkers of intestinal permeability — review

Final Thoughts

The lactulose–mannitol test turns an invisible biological property into measurable evidence by following two molecular travellers. Its power lies in that functional design; its limitation is that no journey occurs in isolation. Probe size, absorptive surface, transit, kidneys, hydration, timing, collection and laboratory method all shape the result. The clearest interpretation keeps the individual probes, the ratio, the protocol and the person’s wider digestive story in view together.